{"entity":{"type":"insider","cik":"0001578845","url":"/insider/0001578845","json_url":"/insider/0001578845.json","name":"Actavis plc","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001578845"},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2014-03-11","last":"2014-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Actavis plc","source":"filing","n_filings":3,"first_seen":"2014-03-11","last_seen":"2014-07-07"}],"transactions":[{"id":6493333,"accession":"0001209191-14-046288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-046288","line_url":"/filing/0001209191-14-046288#line-1","is_derivative":false,"issuer_cik":"0000038074","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0000038074","owner_cik":null,"owner_name":"Actavis plc; Forest Laboratories, LLC","owner_display_name":"Actavis plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11169066.0,"shares_display":"11,169,066","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":1061061270.0,"total_display":"1,061,061,270.00","total_whole":"1,061,061,270","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-02","filed_date":"2014-07-07","scope":"insider"},{"id":9242074,"accession":"0001179110-14-005102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-005102","line_url":"/filing/0001179110-14-005102#line-1","is_derivative":false,"issuer_cik":"0001496606","issuer_name":"COLUMBIA LABORATORIES INC","issuer_ticker":"CBRX","issuer_name_source":null,"issuer_url":"/issuer/0001496606","owner_cik":null,"owner_name":"Actavis plc; COVENTRY ACQUISITION, LLC","owner_display_name":"Actavis plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400000.0,"shares_display":"1,400,000","price_per_share":6.0779,"price_display":"6.08","price_state":"stated","total_value":8509060.0,"total_display":"8,509,060.00","total_whole":"8,509,060","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-12","scope":"insider"},{"id":6720365,"accession":"0001179110-14-004981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-004981","line_url":"/filing/0001179110-14-004981#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"COLUMBIA LABORATORIES INC","issuer_ticker":"CBRX","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":null,"owner_name":"COVENTRY ACQUISITION, LLC; Actavis plc","owner_display_name":"COVENTRY ACQUISITION, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400000.0,"shares_display":"1,400,000","price_per_share":5.76,"price_display":"5.76","price_state":"stated","total_value":8064000.0,"total_display":"8,064,000.00","total_whole":"8,064,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001484478","name":"Furiex Pharmaceuticals, Inc.","url":"/issuer/0001484478","role":"Ten percent owner","n_filings":1,"first_seen":"2014-07-07","last_seen":"2014-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000821995","name":"COLUMBIA LABORATORIES INC","url":"/issuer/0000821995","role":"Ten percent owner","n_filings":2,"first_seen":"2014-03-11","last_seen":"2014-03-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578845","retrieved_at":"2026-08-27T13:59:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}